DDC
CLB icon

DF Dent & Co’s Core Laboratories CLB Stock Holding History

DF Dent & Co’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-21,607
Closed -$1.01M – 222
2019
Q3 		$1.01M Sell
21,607
-308,341
-93% -$14.3M 0.02% 136
2019
Q2 		$17.3M Buy
329,948
+11,536
+4% +$677K 0.31% 43
2019
Q1 		$21.9M Sell
318,412
-209,318
-40% -$14M 0.44% 42
2018
Q4 		$31.5M Sell
527,730
-278,810
-35% -$24.1M 0.79% 41
2018
Q3 		$93.4M Sell
806,540
-2,504
-0.3% -$283K 1.94% 25
2018
Q2 		$102M Sell
809,044
-4,513
-0.6% -$549K 2.3% 19
2018
Q1 		$88M Buy
813,557
+106,585
+15% +$11.8M 2.04% 24
2017
Q4 		$77.4M Buy
+706,972
New +$70.6M 1.95% 24
2016
Q4 		– Sell
-17,985
Closed -$2.02M – 184
2016
Q3 		$2.02M Sell
17,985
-1,000
-5% -$115K 0.06% 68
2016
Q2 		$2.35M Hold
18,985
– – 0.07% 65
2016
Q1 		$2.13M Sell
18,985
-4,845
-20% -$503K 0.06% 67
2015
Q4 		$2.59M Buy
23,830
+4,695
+25% +$537K 0.07% 66
2015
Q3 		$1.91M Sell
19,135
-9,514
-33% -$1.03M 0.05% 71
2015
Q2 		$3.27M Sell
28,649
-513,128
-95% -$62.2M 0.09% 59
2015
Q1 		$56.6M Sell
541,777
-21,216
-4% -$2.26M 1.4% 32
2014
Q4 		$67.8M Sell
562,993
-36,293
-6% -$4.77M 1.65% 27
2014
Q3 		$87.7M Buy
599,286
+248,396
+71% +$38.3M 2.18% 20
2014
Q2 		$58.6M Sell
350,890
-5,570
-2% -$991K 1.36% 33
2014
Q1 		$70.7M Buy
356,460
+2,159
+0.6% +$408K 1.65% 30
2013
Q4 		$67.7M Buy
354,301
+8,732
+3% +$1.63M 1.54% 28
2013
Q3 		$58.5M Sell
345,569
-604
-0.2% -$93.8K 1.51% 27
2013
Q2 		$52.5M Buy
+346,173
New +$49M 1.49% 30

Other funds holding CLB

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return

DF Dent & Co's CLB Position: Q4 2019 in Review

DF Dent & Co sold out of Core Laboratories (CLB) in Q4 2019, closing a stake of 21,607 shares — an estimated $1.01M sold.

DF Dent & Co first reported a position in CLB in Q2 2013 and held it in 22 quarters. The position peaked at $102M in Q2 2018. 283 funds tracked by Wall St. Rank hold CLB as of Q4 2019.

  • DF Dent & Co reported no remaining Core Laboratories position as of Q4 2019 after selling out during the quarter.
  • DF Dent & Co sold 21,607 Core Laboratories shares in Q4 2019, an estimated $1.01M.
  • DF Dent & Co first reported a position in Core Laboratories in Q2 2013 and held it in 22 quarters.
  • DF Dent & Co's Core Laboratories position peaked at $102M in Q2 2018.
  • 283 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2019.

Based on DF Dent & Co's 13F filing for Q4 2019, filed 14 Feb 2020.